tiprankstipranks
Travere Therapeutics (TVTX)
NASDAQ:TVTX

Travere Therapeutics (TVTX) Similar Stocks

Compare
446 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Travere Therapeutics
$23.58
$1.97B
200.00%
12 Buy
1 Hold
0 Sell
Strong Buy
Amgen
$297.93
$160.05B
39.41
8.31%
11 Buy
7 Hold
1 Sell
Moderate Buy
BioMarin Pharmaceutical
$68.73
$12.36B
39.51
-22.37%
18 Buy
5 Hold
0 Sell
Strong Buy
Vertex Pharmaceuticals
$480.33
$118.67B
14.47%
15 Buy
12 Hold
1 Sell
Moderate Buy
Sarepta Therapeutics
$108.41
$10.36B
90.06
-18.05%
13 Buy
1 Hold
1 Sell
Strong Buy
Ultragenyx Pharmaceutical
$44.48
$4.03B
-9.00%
15 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
TVTX
Travere Therapeutics
23.58
15.70
199.24%
AMGN
Amgen
297.93
22.86
8.31%
BMRN
BioMarin Pharmaceutical
68.73
-19.81
-22.37%
VRTX
Vertex Pharmaceuticals
480.33
60.70
14.47%
SRPT
Sarepta Therapeutics
108.41
-23.88
-18.05%
RARE
Ultragenyx Pharmaceutical
44.48
-3.70
-7.68%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis